According to the research report titled ‘Global Covid-19 Vaccine Market - Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)’, available with MarketStudyReport, global Covid-19 vaccine market to amass a valuation of USD 25 billion by the year 2024.
 

Increasing government support for vaccine development, as well as involvement of worldwide organizations in the creation of suitable immunization facilities in endemic areas are the major growth determinants for global covid-19 vaccine market growth.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3578555/
 

Furthermore, increasing demand for coronavirus vaccine, ongoing government activities to procure the vaccine, and outbreaks of infection waves are expected to drive industry expansion over the forecast period.
 

On the basis of product type, the marketplace is divided into monovalent vaccine, and multivalent vaccine.
 

In terms of patient type, the market is divided into senior citizens, adult, and pediatric. Among these, senior citizens segment is poised to hold significant market share over the forecast period, owing to government measures to vaccinate the vulnerable population on priority basis.
 

With respect to end-user terrain, global Covid-19 vaccine industry is branched into clinics, vaccination centers, hospitals, academic & research institute, and others. The hospitals segment is anticipated to hold substantial market share in the forthcoming years, due to the measures taken by healthcare authorities and government to vaccinate the population in order to avoid the further spread of coronavirus disease.
 

Considering the regional landscape, North America, followed by Europe and Asia Pacific, is reckoned to see significant growth thorough 2024, because of the second and third waves of coronavirus, the rise of mutant viruses, the presence of different leading manufacturers in the region with companies gearing up their production capacity, and the increasing number of coronavirus patients.
 

The key players in worldwide Covid-19 vaccine marketplace are Astellas Pharma Inc., Daiichi Sankyo Co., Ltd., CSL Limited, Abbott Laboratories, GlaxoSmithKline plc, Moderna Inc., BioNTech SE, Novavax Inc., Johnson & Johnson (J&J), and AstraZeneca plc.